Compare Eaton Corporation plc (ETN) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Eaton Corporation plc trades at $430.66 (market cap $164.88B), while Halozyme Therapeutics Inc. Common Stock trades at $112.28 (market cap $12.58B). The key difference: Eaton Corporation plc is far larger — about 13.1× Halozyme Therapeutics Inc. Common Stock's market cap, and Eaton Corporation plc pays a 1.04% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| ETN | HALO | |
|---|---|---|
Market Cap | $164.88B | $12.58B |
Volume | 2,535,086 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $459.96 | $115.22 |
52-Week Low | $315.82 | $61.63 |
Typical Hold Time | 31 Days | 1 Days |
Enterprise Value | $185.51B | $14.49B |
Dividend Yield | 1.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $430.25, down 0.25% with bearish technical signals but strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, maintains healthy margins (12.75% net income), and benefits from strategic acquisitions in data center and aerospace markets. Analyst consensus remains strongly bullish with a $502.38 price target, though technical indicators show near-term pressure with support at $418.
ETN presents a compelling growth story driven by AI data center demand and grid modernization trends, but faces execution risks from recent acquisitions and competitive pressure from peers like Vertiv. The stock's premium valuation (P/E 43.23) requires sustained earnings growth to justify, making upcoming Q3 earnings on November 5 critical for momentum.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
